Human Malignant Gliomas Secrete a Factor that Increases Brain Capillary Permeability: Role in Peritumoural Brain Oedema
The effect of conditioned media obtained from two human malignant gliomas and normal human glia on rat brain capillary permeability was investigated by measuring the entry of 14C-aminoisobutyric acid by a quantitative autoradiographic method. Conditioned media were concentrated 50-fold to create SUP-C. The SUP-C contained proteins with a molecular weight greater than 10 kD. The SUP-C from glioma cells markedly increased brain capillary permeability, whereas that from normal glial cells did not. The activity of capillary permeability factor in the SUP-C was significantly inhibited by pretreatment of animals with dexamethasone or BW755C (lipoxygenase inhibitor), but not with indomethacin. On the other hand, coincubation of glioma cells with dexamethasone produced SUP-C whose capillary permeability activity was about one and a half times greater than that without dexamethasone. These results indicate that human malignant glioma cells secrete a protein factor that increases brain capillary permeability. Glucocorticoids inhibit the effect of the factor by directly acting on capillary endothelial cells, possibly through the inhibition of phospholipase A2 activity, resulting in a decrease of lipoxygenase rather than cyclo-oxygenase products.
KeywordsConditioned Medium Glioma Cell Malignant Glioma Capillary Endothelial Cell Capillary Permeability
Unable to display preview. Download preview PDF.
- 4.Hirata F (1918) The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem 256: 7730–7733Google Scholar
- 7.Ohnishi T, Shapiro WR (1987) Vascular permeability factors produced by brain tumours: possible role in peritumoural brain oedema. J Neuro-Oncol 5: 179Google Scholar
- 8.Ohnishi T, Sher PB, Posner JB et al (1990) Increased capillary permeability in rat brain induced by factors secreted by cultured C6 glioma cells: role in peritumoural brain oedema. J NeuroOncol (in press)Google Scholar